{
  "id": "R-ISS_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-12-22",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To provide better discrimination of prognosis for MM based on the genetics and other routinely used lab values in conjunction with the original ISS Staging System.",
        "keywords": [
          "Multiple Myeloma",
          "albumin",
          "LDH",
          "iFISH"
        ],
        "use": "Use only in patients recently diagnosed with multiple myeloma. \n\nFormula: \n1. Assign ISS stage:\n\n                                                                                                      Serum albumin, g/dL\n                                                                                                  ≥3.5                              <3.5\nSerum β2 microglobulin, mg/L  <3.5                                    ISS I                              ISS II\n                                                         3.5-5.4                                ISS II                             ISS II\n                                                         ≥5.5                                    ISS III                           ISS III\n\n\n2. Stage R-ISS according to iFISH and LDH:\n\n                                                                            High-risk cytogenetic abnormalities by iFISH*              LDH\n                                                                                No                                    Yes                                        Normal/High\n\nISS I                                                                         R-ISS I                              R-ISS II                                   Normal\n                                                                                R-ISS II                             R-ISS II                                    High\n\nISS II                                                                         R-ISS II                             R-ISS II                                    Normal\n                                                                                 R-ISS II                             R-ISS II                                    High\n\nISS III                                                                        R-ISS II                             R-ISS III                                   Normal\n                                                                                 R-ISS III                            R-ISS III                                   High\n\n*High-risk = presence of del(17p) and/or translocation t(4;14) and/or translocation t(14;16).                                   \nR-ISS interpretation:\nR-ISS Stage               Median progression-free survival\nI                                  66 months\nII                                 42 months\nIII                                29 months\n\n",
        "misuse": "Not to use in patients with relapsed myeloma, smoldering myeloma or MGUS.",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Palumbo A, et. al. Revised International Staging System for Multiple Myeloma: a Report From International Myeloma Working Group. JCO 2015; 33: 2863-2869.\n"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-OBSERVATION.r_iss.v0",
        "template_id": "openEHR-EHR-OBSERVATION.r_iss.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0021]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0028]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0017]"
          }
        }
      },
      "gt0004": {
        "id": "gt0004",
        "model_id": "openEHR-EHR-OBSERVATION.r_iss.v0",
        "template_id": "openEHR-EHR-OBSERVATION.r_iss.v0",
        "type": "INPUT",
        "elements": {
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0011]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0014]"
          }
        }
      }
    },
    "rules": {
      "gt0013": {
        "id": "gt0013",
        "priority": 6,
        "when": [
          "$gt0005|Serum β2 microglobulin|==1|local::at0005|<3.5 mg/L|",
          "$gt0006|Serum albumin|==2|local::at0010|≥3.5 g/dL|"
        ],
        "then": [
          "$gt0015|ISS stage|=local::at0032|ISS I|"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 5,
        "when": [
          "(($gt0005|Serum β2 microglobulin|==1|local::at0005|<3.5 mg/L|)&&($gt0006|Serum albumin|==1|local::at0009|<3.5 g/dL|))||(($gt0005|Serum β2 microglobulin|==2|local::at0006|3.5-5.4 mg/L|)&&($gt0006|Serum albumin|!=null))"
        ],
        "then": [
          "$gt0015|ISS stage|=local::at0033|ISS II|"
        ]
      },
      "gt0016": {
        "id": "gt0016",
        "priority": 4,
        "when": [
          "$gt0005|Serum β2 microglobulin|==3|local::at0007|>5.4 mg/L|",
          "$gt0006|Serum albumin|!=null"
        ],
        "then": [
          "$gt0015|ISS stage|=local::at0034|ISS III|"
        ]
      },
      "gt0017": {
        "id": "gt0017",
        "priority": 3,
        "when": [
          "$gt0015|ISS stage|==local::at0032|ISS I|",
          "$gt0007|CA by iFISH|==1|local::at0012|Standard risk|",
          "$gt0008|LDH|==1|local::at0015|Normal (< upper limit of normal)|"
        ],
        "then": [
          "$gt0012|R-ISS Stage|=local::at0029|R-ISS Stage I|",
          "$gt0011|Median progression-free survival|=local::at0024|66 months median progression-free survival|"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 2,
        "when": [
          "((($gt0015|ISS stage|==local::at0032|ISS I|)&&($gt0007|CA by iFISH|==1|local::at0012|Standard risk|))&&($gt0008|LDH|==2|local::at0016|High (> upper limit of normal)|))||(((($gt0015|ISS stage|==local::at0032|ISS I|)&&($gt0007|CA by iFISH|==2|local::at0013|High risk|))&&($gt0008|LDH|!=null))||(((($gt0015|ISS stage|==local::at0033|ISS II|)&&($gt0007|CA by iFISH|!=null))&&($gt0008|LDH|!=null))||((($gt0015|ISS stage|==local::at0034|ISS III|)&&($gt0007|CA by iFISH|==1|local::at0012|Standard risk|))&&($gt0008|LDH|==1|local::at0015|Normal (< upper limit of normal)|))))"
        ],
        "then": [
          "$gt0012|R-ISS Stage|=local::at0030|R-ISS Stage II|",
          "$gt0011|Median progression-free survival|=local::at0023|42 months median progression-free survival|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 1,
        "when": [
          "((($gt0015|ISS stage|==local::at0034|ISS III|)&&($gt0007|CA by iFISH|==1|local::at0012|Standard risk|))&&($gt0008|LDH|==2|local::at0016|High (> upper limit of normal)|))||((($gt0015|ISS stage|==local::at0034|ISS III|)&&($gt0007|CA by iFISH|==2|local::at0013|High risk|))&&($gt0008|LDH|!=null))"
        ],
        "then": [
          "$gt0012|R-ISS Stage|=local::at0031|R-ISS Stage III|",
          "$gt0011|Median progression-free survival|=local::at0022|29 months median progression-free survival|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "R-ISS",
            "description": "Revised Multiple Myeloma International Staging System (R-ISS)"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Serum β2 microglobulin",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Serum albumin",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "CA by iFISH",
            "description": "High risk defined as: presence of del(17p) and/or translocation t(4;14) and/or translocation t(14;16)"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "LDH",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Median progression-free survival",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "R-ISS Stage",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Set ISS I"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Set ISS II"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "ISS stage",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Set ISS III"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Set R-ISS Stage I"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Set R-ISS Stage II"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Set R-ISS Stage III"
          }
        }
      }
    }
  }
}